Company Details
Sector | PHARMACEUTICALS |
Address | 35 - Dockyard Road West Wharf Karachi |
Auditor | Yousuf Adil, Chartered Accountants |
Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
Website | www.pk.gsk.com |
Fiscal Year | December |
Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
Date/Time | Announcement |
---|---|
22/10/2008 12:55:40 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,744.523 EPS = 5.91 FINANCIAL RESULT FOR THE THIRD QUARTER ENDED 30/09/2OO8 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,009.523 |
12/08/2008 13:03:11 | BOOK CLOSURE TO 08/09/2008 DIVIDEND = 25%(i) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,227.964 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 734.964 EPS = 4.31 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2OO8 BOOK CLOSURE FROM 01/09/2008 |
23/04/2008 12:31:44 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 729.610 EPS = 2.62 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2OO8 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 446.610 |
22/02/2008 15:01:30 | BOOK CLOSURE TO 31/03/2008 BOOK CLOSURE FROM 25/03/2008 ANNUAL GENERAL MEETING WILL BE HELD ON 31/03/2OO8 EPS = 9.79 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,670.525 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,658.543 DIVIDEND = 75%(F) FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2OO7 |
29/10/2007 11:10:18 | FINANCIAL RESULT FOR THE THIRD QUARTER ENDED 30/09/2OO7 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,016.162 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,245.662 EPS = 7.30 |